Evidence map›Paper›PMID 33957766›Full record

ArticlePsychiatric services (Washington, D.C.)2021

Effects of the ACA on Health Care Coverage for Adults With Substance Use Disorders.

Mark Olfson, Melanie M Wall, Colleen L Barry, Christine Mauro, C Jean Choi, Ramin Mojtabai

Abstract read
In one paragraph

Article in Psychiatric services (Washington, D.C.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mark OlfsonVagelos College of Physicians and Surgeons, Columbia University, New York City (Olfson, Wall); New York State Psychiatric Institute, New York City (Olfson, Wall, Mauro, Choi); Departments of Mental Health (Mojtabai and Barry) and Health Policy and Management (Barry), Johns Hopkins Bloomberg School of Public Health, and Department of Psychiatry and Behavioral Sciences, School of Medicine, Johns Hopkins University, Baltimore (Mojtabai).
Melanie M WallVagelos College of Physicians and Surgeons, Columbia University, New York City (Olfson, Wall); New York State Psychiatric Institute, New York City (Olfson, Wall, Mauro, Choi); Departments of Mental Health (Mojtabai and Barry) and Health Policy and Management (Barry), Johns Hopkins Bloomberg School of Public Health, and Department of Psychiatry and Behavioral Sciences, School of Medicine, Johns Hopkins University, Baltimore (Mojtabai).
Colleen L BarryVagelos College of Physicians and Surgeons, Columbia University, New York City (Olfson, Wall); New York State Psychiatric Institute, New York City (Olfson, Wall, Mauro, Choi); Departments of Mental Health (Mojtabai and Barry) and Health Policy and Management (Barry), Johns Hopkins Bloomberg School of Public Health, and Department of Psychiatry and Behavioral Sciences, School of Medicine, Johns Hopkins University, Baltimore (Mojtabai).
Christine MauroVagelos College of Physicians and Surgeons, Columbia University, New York City (Olfson, Wall); New York State Psychiatric Institute, New York City (Olfson, Wall, Mauro, Choi); Departments of Mental Health (Mojtabai and Barry) and Health Policy and Management (Barry), Johns Hopkins Bloomberg School of Public Health, and Department of Psychiatry and Behavioral Sciences, School of Medicine, Johns Hopkins University, Baltimore (Mojtabai).
C Jean ChoiVagelos College of Physicians and Surgeons, Columbia University, New York City (Olfson, Wall); New York State Psychiatric Institute, New York City (Olfson, Wall, Mauro, Choi); Departments of Mental Health (Mojtabai and Barry) and Health Policy and Management (Barry), Johns Hopkins Bloomberg School of Public Health, and Department of Psychiatry and Behavioral Sciences, School of Medicine, Johns Hopkins University, Baltimore (Mojtabai).
Ramin MojtabaiVagelos College of Physicians and Surgeons, Columbia University, New York City (Olfson, Wall); New York State Psychiatric Institute, New York City (Olfson, Wall, Mauro, Choi); Departments of Mental Health (Mojtabai and Barry) and Health Policy and Management (Barry), Johns Hopkins Bloomberg School of Public Health, and Department of Psychiatry and Behavioral Sciences, School of Medicine, Johns Hopkins University, Baltimore (Mojtabai).

Funding

Towards a Comprehensive Developmental Model of Substance Use DisordersR01DA019606 · NIDA · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI OLFSON, MARK · 2006 to 2016
$2.6M
Health Care Policy and Substance Abuse Treatment AccessR01DA039137 · NIDA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MOJTABAI, RAMIN, OLFSON, MARK · 2017 to 2022
$1.9M
NIDA NIH HHS R01 DA019606NIDA NIH HHS R01 DA039137
6 · The paper itself

Abstract

objectiveThe authors assessed changes in health care coverage in nationally representative samples of low- and middle-income adults with and without substance use disorders following the 2014 Affordable Care Act marketplace launch and Medicaid expansion.

methodsData from the 2012-2018 (N=407,985) National Survey on Drug Use and Health identified low- and middle-income nonelderly adults with alcohol, marijuana, cocaine, or heroin use disorders. A sociodemographically adjusted difference-in-differences analysis assessed the trends in Medicaid and individually purchased private insurance between adults with and without substance use disorders.

resultsBetween 2012-2013 and 2015-2016, the percentages without health insurance significantly declined for adults with substance use disorders (from 27.8% to 18.7%) and for those without these disorders (from 22.6% to 14.6%). These trends were related to gains in Medicaid and in individually purchased private insurance but not to gains in employer-based private insurance coverage. Between 2015-2016 and 2017-2018, however, the percentages without health insurance among adults with substance use disorders (18.7% to 18.4%) and without these disorders (14.7% to 14.7%) was little changed.

conclusionsWith insurance gains having stalled and the downturn of the U.S. economy, there is renewed urgency to extend health care coverage to middle- and low-income adults with substance use disorders that meets their substance use and general health needs.

Indexed as

Patient Protection and Affordable Care ActSubstance-Related DisordersAdultHealth Services AccessibilityHumansInsurance CoverageInsurance, HealthMedicaidUnited StatesAlcohol and drug abuseHealth care reform

Identifiers

PMID33957766
PMCPMC8328862

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.